Spectranetics, FDA Discuss Laser Indication Approval After Panel Says No
This article was originally published in The Gray Sheet
Executive Summary
Spectranetics plans to use a 50-patient Belgium study to shore up support for an indication covering its CVX-300 excimer laser catheter system for critical limb ischemia patients with lesions not crossable with a guidewire